Proceedings: General practitioner studies of beta-blockade in hypertension.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D001581:Benzothiadiazines; D003499:Cyclic S-Oxides / Q000008:administration & dosage / Q000627:therapeutic use; D003517:Cyclopentanes / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics; D004357:Drug Synergism; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000008:administration & dosage* / Q000627:therapeutic use; D010096:Oxprenolol / Q000008:administration & dosage* / Q000627:therapeutic use; D011189:Potassium Chloride / Q000008:administration & dosage* / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D003499:Cyclic S-Oxides; D003517:Cyclopentanes; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D010096:Oxprenolol; D008750:Methyldopa; D011189:Potassium Chloride